Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aso InternationalTSE:9340 +0.84%58 Return-on-Tangible-Equity is 0.00% as of Dec. 2025. GuruFocus rates TSE:9340 with a GF Score™ of 58/100 and a GF Value™ of 円649.52 (Modestly Overvalued). The stock has 1 warning sign investors should review. Among 759 Medical Devices & Instruments companies, Aso International ranks better than 73.12% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Aso International's annualized net income for the quarter that ended in Dec. 2025 was 円0 Mil. Aso International's average shareholder tangible equity for the quarter that ended in Dec. 2025 was 円2,911 Mil. Therefore, Aso International's annualized Return-on-Tangible-Equity for the quarter that ended in Dec. 2025 was 0.00%.
The historical rank and industry rank for Aso International's Return-on-Tangible-Equity or its related term are showing as below:
TSE:9340'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 12.79 Med: 17.16 Max: 31.77
Current: 12.79
During the past 5 years, Aso International's highest Return-on-Tangible-Equity was 31.77%. The lowest was 12.79%. And the median was 17.16%.
TSE:9340's Return-on-Tangible-Equity is ranked better than 73.12% of 759
companies
in the Medical Devices & Instruments industry
Industry Median: 4.04
vs TSE:9340: 12.79
Aso International (TSE:9340) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Aso International Return-on-Tangible-Equity Related Terms
Aso International Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Aso International's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:9340 vs ISRG, BDX, MDLN: Return-on-Tangible-Equity Comparison
For the Medical Instruments & Supplies subindustry, Aso International's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aso International Return-on-Tangible-Equity vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aso International's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Aso International's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Dec. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.00% mean?
Aso International (TSE:9340) has a Return-on-Tangible-Equity of 0.00% as of Dec. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aso International and its competitors. Over the past decade, Aso International's Return-on-Tangible-Equity has ranged from 12.79 to 31.77. According to the industry distribution chart, Aso International ranks #204 out of 759 companies in the Medical Devices & Instruments industry, placing it in the top 26.9%.
Is Aso International's Return-on-Tangible-Equity too high?
Aso International's current Return-on-Tangible-Equity is 0.00%. Over the past 10 years, this metric has ranged from a low of 12.79 to a high of 31.77. Based on the distribution chart, Aso International ranks #204 out of 759 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Aso International has a GF Score™ of 58/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Aso International's Return-on-Tangible-Equity compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aso International ranks #204 out of 759 companies for Return-on-Tangible-Equity. This puts Aso International in the upper half of its industry. The industry median Return-on-Tangible-Equity is 4.04. Historically, Aso International's own Return-on-Tangible-Equity has ranged from 12.79 to 31.77 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Devices & Instruments company?
The median Return-on-Tangible-Equity among Medical Devices & Instruments companies is 4.04, based on 759 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Aso International and its competitors. For the Medical Devices & Instruments industry, the median Return-on-Tangible-Equity is 4.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aso International's current Return-on-Tangible-Equity is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aso International stock overvalued right now?
Based on GuruFocus' analysis, Aso International (TSE:9340) is currently considered Modestly Overvalued. The stock's GF Value™ is 円649.52, compared to a current price of 円718.00 — trading 10.5% above its estimated fair value. The current Return-on-Tangible-Equity is 0.00%. Aso International's overall GF Score™ is 58/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Aso International (TSE:9340), the current Return-on-Tangible-Equity is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aso International (TSE:9340) Overvalued in 2026?
Based on GuruFocus' analysis, Aso International stock appears to be overvalued.
The current stock price of 円718.00 is trading 10.5% above its estimated GF Value™ of 円649.52.
GuruFocus considers Aso International to be Modestly Overvalued.
Key valuation signals for TSE:9340:
Return-on-Tangible-Equity: 0.00%
GF Value™: 円649.52 vs. price of 円718.00 (10.5% above fair value)
No single metric tells the full story. See the TSE:9340 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aso International Inc is engaged in the manufacturing and sale of orthodontic appliances. The company mainly manufactures and supplies custom-made orthodontic dental prostheses to dental medical institutions. Its product portfolio comprises Aso Liner, Specter 4D Print Retainer, 3D printers for dental prostheses, Harmony, a lingual orthodontic system, and various types of retainers, among others. The group operates in a single segment, the orthodontic business.
58GF Score
Get the complete analysis for TSE:9340
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:9340 has been successfully added to your 
